z-logo
open-access-imgOpen Access
Documenting the Natural History of Patients With Resected Stage II Adenocarcinoma of the Colon After Random Assignment to Adjuvant Treatment With Edrecolomab or Observation: Results From CALGB 9581
Author(s) -
Doniedzwiecki,
Monica M. Bertagnolli,
Robert S. Warren,
Carolyn C. Compton,
Nancy E. Kemeny,
Al B. Benson,
Sabine Eckhardt,
Steven R. Alberts,
Gity N. Porjosh,
Rachel Kerr,
Anthony Fields,
Philippe Rougier,
J. Marc Pipas,
Joel H. Schwartz,
James N. Atkins,
Mark Allen O’Rourke,
Michael C. Perry,
Richard M. Goldberg,
Robert J. Mayer,
Thomas A. Colacchio
Publication year - 2011
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2010.32.5357
Subject(s) - medicine , colorectal cancer , stage (stratigraphy) , adjuvant therapy , natural history , cancer , surgery , adjuvant , cohort , adenocarcinoma , oncology , paleontology , biology
We conducted a randomized trial comparing adjuvant treatment with edrecolomab versus observation in patients with resected, low-risk, stage II colon cancer. This study also prospectively studied patient- and tumor-specific markers of treatment outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom